[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100609769":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":20,"locations":26,"responsibleParty":149,"collaborators":19,"id":151,"slug":19,"hasResults":152,"nctId":153,"briefTitle":154,"officialTitle":155,"acronym":156,"eligibilityCriteria":157,"healthyVolunteers":152,"sex":158,"minAge":159,"maxAge":160,"enrollmentInfo":161,"targetDuration":19,"studyType":164,"phases":165,"briefSummary":168,"conditions":169,"keywords":171,"overallStatus":29,"whyStopped":19,"lastUpdateSubmitDate":173,"lastUpdatePostDateStruct":174,"startDateStruct":177,"completionDateStruct":179,"leadSponsor":181,"locationsCount":182},{"fullName":5,"class":6},"Alexion Pharmaceuticals, Inc.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"ALXN2350","EXPERIMENTAL","Participants will receive one of three dose levels of ALXN2350 depending on the cohort.",[13],"Drug: ALXN2350",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"DRUG","ALXN2350 is a gene therapy product consisting of an AAV9 capsid containing BAG3 transgene. It is administered as a single intravenous (IV) infusion.",[9],null,[21],{"name":22,"role":23,"phone":24,"phoneExt":19,"email":25},"Alexion Pharmaceuticals, Inc. (Sponsor)","CONTACT","1-855-752-2356","clinicaltrials@alexion.com",[27,45,59,73,87,101,114,123,132,140],{"facility":28,"status":29,"city":30,"state":31,"zip":32,"country":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"Research Site","RECRUITING","Birmingham","Alabama","35233","United States",{"type":35,"coordinates":36},"Point",[37,38],-86.80249,33.52066,{"lat":38,"lon":37},[41],{"name":42,"role":23,"phone":43,"phoneExt":19,"email":44},"Nehal Vekariya","205-934-7173","nvekariya@uabmc.edu",{"facility":28,"status":29,"city":46,"state":47,"zip":48,"country":33,"cosmosGeoPoint":49,"geoPoint":53,"contacts":54},"Boston","Massachusetts","02115",{"type":35,"coordinates":50},[51,52],-71.05977,42.35843,{"lat":52,"lon":51},[55],{"name":56,"role":23,"phone":57,"phoneExt":19,"email":58},"Alyx Vogle","617-732-6320","avogle@bwh.harvard.edu",{"facility":28,"status":29,"city":60,"state":61,"zip":62,"country":33,"cosmosGeoPoint":63,"geoPoint":67,"contacts":68},"Cincinnati","Ohio","45219",{"type":35,"coordinates":64},[65,66],-84.51439,39.12711,{"lat":66,"lon":65},[69],{"name":70,"role":23,"phone":71,"phoneExt":19,"email":72},"Michael Weber","513-585-1777","michael.weber@thechristhospital.com",{"facility":28,"status":29,"city":74,"state":75,"zip":76,"country":33,"cosmosGeoPoint":77,"geoPoint":81,"contacts":82},"Portland","Oregon","97239-3098",{"type":35,"coordinates":78},[79,80],-122.67621,45.52345,{"lat":80,"lon":79},[83],{"name":84,"role":23,"phone":85,"phoneExt":19,"email":86},"Hailey Volk","503-418-2246","volkh@ohsu.edu",{"facility":28,"status":29,"city":88,"state":89,"zip":90,"country":33,"cosmosGeoPoint":91,"geoPoint":95,"contacts":96},"Philadelphia","Pennsylvania","19104",{"type":35,"coordinates":92},[93,94],-75.16362,39.95238,{"lat":94,"lon":93},[97],{"name":98,"role":23,"phone":99,"phoneExt":19,"email":100},"Joseph Puhl","267-399-3049","joseph.puhl@pennmedicine.upenn.edu",{"facility":28,"status":29,"city":102,"state":103,"zip":104,"country":33,"cosmosGeoPoint":105,"geoPoint":109,"contacts":110},"Houston","Texas","77030",{"type":35,"coordinates":106},[107,108],-95.36327,29.76328,{"lat":108,"lon":107},[111],{"name":112,"role":23,"phone":113,"phoneExt":19,"email":19},"Jennifer Garrett","346-238-4516",{"facility":28,"status":29,"city":115,"state":19,"zip":116,"country":117,"cosmosGeoPoint":118,"geoPoint":122,"contacts":19},"Massa","54100","Italy",{"type":35,"coordinates":119},[120,121],10.13927,44.03541,{"lat":121,"lon":120},{"facility":28,"status":29,"city":124,"state":19,"zip":125,"country":126,"cosmosGeoPoint":127,"geoPoint":131,"contacts":19},"Barcelona","08035","Spain",{"type":35,"coordinates":128},[129,130],2.15899,41.38879,{"lat":130,"lon":129},{"facility":28,"status":29,"city":133,"state":19,"zip":134,"country":126,"cosmosGeoPoint":135,"geoPoint":139,"contacts":19},"Majadahonda","28222",{"type":35,"coordinates":136},[137,138],-3.87182,40.47353,{"lat":138,"lon":137},{"facility":28,"status":29,"city":141,"state":19,"zip":142,"country":143,"cosmosGeoPoint":144,"geoPoint":148,"contacts":19},"London","SW3 6NP","United Kingdom",{"type":35,"coordinates":145},[146,147],-0.12574,51.50853,{"lat":147,"lon":146},{"type":150,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR","100609769",false,"NCT07218887","ALXN2350 in Adult Participants With BAG3-Associated Dilated Cardiomyopathy","A Phase 1\u002F2, Open-Label, Multicenter, Dose Finding and Dose Expansion Study to Investigate the Safety, Tolerability, and Efficacy of ALXN2350 Gene Therapy in Adult Participants With BAG3 Mutation Associated Dilated Cardiomyopathy","DCMRestore","Inclusion Criteria:\n\n* Pathogenic or likely pathogenic mutation in BAG3\n* Medical history of diagnosis of DCM\n* Stable combination of HF SoC medications\n* Adequate acoustic windows for echocardiography\n\nExclusion Criteria:\n\n* Presence of antibodies to AAV9\n* Presence of a pathogenic or likely pathogenic variant in another gene where that other gene is authoritatively recognized as causal for DCM.\n* Decompensated HF\n\nNote: Other inclusion and exclusion criteria may apply.","ALL","18 Years","70 Years",{"count":162,"type":163},6,"ESTIMATED","INTERVENTIONAL",[166,167],"PHASE1","PHASE2","This Phase 1\u002F2 study is an open-label, dose finding and dose expansion study investigating the safety, tolerability, and efficacy of a single IV infusion of ALXN2350 in adult participants with BAG3 associated DCM.",[170],"BAG3 Mutation Associated Dilated Cardiomyopathy",[9,172,170],"Gene Therapy","2026-06-12",{"date":175,"type":176},"2026-06-15","ACTUAL",{"date":178,"type":176},"2025-10-24",{"date":180,"type":163},"2032-01-27",{"name":5,"class":6},10]